Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 3Dermatologic 3Gynecologic 2Genitourinary 2CNS 2Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Neuroblastoma 17Glioblastoma 11Melanoma 5Brain Neoplasms 5Rhabdoid Tumor 4Osteosarcoma 4Lymphoma 4Glioma 4Sarcoma, Ewing 3Rhabdomyosarcoma 3Recurrence 3Ovarian Neoplasms 3Neoplasm Metastasis 3Leukemia, Myeloid, Acute 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Wilms Tumor 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pinealoma 2Neurofibromatosis 1 2Neuroectodermal Tumors, Primitive 2Neoplasms, Germ Cell and Embryonal 2Multiple Myeloma 2Meningioma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Liver Neoplasms 2Leukemia, Myelomonocytic, Juvenile 2Hepatoblastoma 2

Interventions

Carboplatin 5Filgrastim 4Thiotepa 3Temozolomide 3Radiotherapy 3Cyclophosphamide 3sargramostim 2fludarabine 2aldesleukin 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Busulfan 2sodium thiosulfate 1pembrolizumab 1ixabepilone 1fludarabine phosphate 1etoposide phosphate 1erythromycin propionate-N-acetylcysteinate 1brodalumab 1Topotecan 1Thrombopoietin 1Tamoxifen 1Stem Cell Transplantation 1Sevoflurane 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Quality of Life 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Liver Neoplasms × fludarabine × CNS × Clear all
NCT07410494 2026-02-18

SELECT-CAR-NK

Essen Biotech

Phase 1/2 Recruiting
85 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Liver Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute

NCT01967823 2021-03-24

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 12 charts
BreastCNSDermatologicGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Liver Neoplasms, Melanoma, Meningioma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡